268 related articles for article (PubMed ID: 25638560)
1. UK Cancer Drugs Fund to reassess 42 agents.
Cagney H
Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
[No Abstract] [Full Text] [Related]
2. Cancer Drugs Fund of minimal benefit.
Burki TK
Lancet Oncol; 2017 Jun; 18(6):e305. PubMed ID: 28483412
[No Abstract] [Full Text] [Related]
3. Careful use of science to advance the debate on the UK Cancer Drugs Fund.
Lakdawalla DN; Jena AB; Doctor JN
JAMA; 2014 Jan; 311(1):25-6. PubMed ID: 24381964
[No Abstract] [Full Text] [Related]
4. Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
Cohen D
BMJ; 2017 Apr; 357():j2097. PubMed ID: 28455308
[No Abstract] [Full Text] [Related]
5. The New and Non-Transparent Cancer Drugs Fund.
Wood EM; Hughes DA
Pharmacoeconomics; 2020 Jan; 38(1):1-4. PubMed ID: 31828737
[No Abstract] [Full Text] [Related]
6. Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.
Emmerich N
Br J Hosp Med (Lond); 2015 Apr; 76(4):186-7. PubMed ID: 25853345
[No Abstract] [Full Text] [Related]
7. A question of health. The lottery of cancer care.
Health Serv J; 1997 Dec; 107(5584):suppl 1-4 following 24. PubMed ID: 10184833
[No Abstract] [Full Text] [Related]
8. Key changes to cancer care in the UK.
Br J Nurs; 2015 Feb 26-Mar 11; 24(4):S3. PubMed ID: 25723370
[No Abstract] [Full Text] [Related]
9. UK and US governments to fund personalised medicine.
Burki T
Lancet Oncol; 2015 Mar; 16(3):e108. PubMed ID: 25660810
[No Abstract] [Full Text] [Related]
10. British clinic is allowed to deny medicine; decision on cost has broad impact.
Lyall S
N Y Times Web; 2006 Feb; ():A10. PubMed ID: 16514743
[No Abstract] [Full Text] [Related]
11. NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.
Kmietowicz Z
BMJ; 2015 Jan; 350():h125. PubMed ID: 25569117
[No Abstract] [Full Text] [Related]
12. UK National Health Service R&D funding--a bureaucratic nightmare.
McCollum C
Lancet; 2003 May; 361(9372):1906. PubMed ID: 12788594
[No Abstract] [Full Text] [Related]
13. Outcomes in patients with recurrent/progressive glioblastoma treated with bevacizumab funded by a regional cancer drug fund.
Dixit S; Hatfield P; Clenton S; Loughrey C; Hingorani M
Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):238-9. PubMed ID: 24461951
[No Abstract] [Full Text] [Related]
14. Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
Hawkes N
BMJ; 2014 Sep; 349():g5382. PubMed ID: 25180006
[No Abstract] [Full Text] [Related]
15. Reforming the cancer drug fund.
Buxton M; Longworth L; Raftery J; Sculpher M; Towse A
BMJ; 2014 Nov; 349():g7276. PubMed ID: 25432928
[No Abstract] [Full Text] [Related]
16. No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog.
Kmietowicz Z
BMJ; 2015 Sep; 351():h4988. PubMed ID: 26384368
[No Abstract] [Full Text] [Related]
17. Budget cuts and the plight of postdocs.
Goozner M
J Natl Cancer Inst; 2013 Feb; 105(3):153-4. PubMed ID: 23334223
[No Abstract] [Full Text] [Related]
18. MPs find no evidence that Cancer Drugs Fund was spent wisely.
Hawkes N
BMJ; 2016 Feb; 352():i755. PubMed ID: 26850036
[No Abstract] [Full Text] [Related]
19. Cancer charity demands extension of drug fund despite criticisms it is unfair.
Limb M
BMJ; 2014 Oct; 349():g6507. PubMed ID: 25354675
[No Abstract] [Full Text] [Related]
20. The Research Assessment Exercise is bad for UK medicine.
Banatvala J; Bell P; Symonds M
Lancet; 2005 Feb 5-11; 365(9458):458-60. PubMed ID: 15705444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
